Global Liver Institute Applauds Congresswoman Velázquez and Senator Duckworth for Bold Action on Liver Cancer
October 22, 2021 10:12 ET | Global Liver Institute
Washington, DC, USA, Oct. 22, 2021 (GLOBE NEWSWIRE) -- (Washington, DC, Friday, October 22, 2021)—Global Liver Institute (GLI) CEO and President, Donna R. Cryer, JD,  yesterday applauded the actions...
New Logo.png
Provectus Biopharmaceuticals Provides Update on Research into Oral Administration of PV-10® Immunotherapy for Treatments of Hematology, Oncology, and Virology
October 04, 2021 09:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s research into the systemic administration of Provectus’ investigational...
Adaptimmune logo Colour_white background_no strap.jpg
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit
September 05, 2021 06:15 ET | Adaptimmune Therapeutics plc
- One complete response, and a disease control rate of 64% with stable disease for ≥16 weeks in two patients, as of the data cutoff - - Data presented today at the International Liver Cancer...
22157.jpg
Global $196.96 Bn Oncology Devices Market to 2025 & 2030: Major Players are Eckert & Ziegler BEBIG, Oncura, GE, Medtronic, Varian Medical Systems, Elekta, Theragenics, Accuray, and Roche Diagnostics
August 20, 2021 06:08 ET | Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
Yiviva_Logo_(R)_1024px_300dpi.png
Yiviva Wins 2 Top Awards at SAPA Investment Forum and Road Show for Innovative Systems Biology Approach to Treat Cancer
July 30, 2021 08:00 ET | Yiviva
NEW YORK and SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage biotechnology company that uses a systems-biology approach to treat aging-associated diseases, won two top...
22157.jpg
Global $3.32 Bn Interventional Oncology Devices Market to 2030: Embolization Devices, Ablation Devices, & Support Devices
July 16, 2021 05:53 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Reports and Data.jpeg-01
Computer Aided Detection (CAD) Market to Reach USD 1579.5 Million In 2028 | Reports and Data
June 09, 2021 09:00 ET | Reports and Data
New York, June 09, 2021 (GLOBE NEWSWIRE) -- Rising prevalence of chronic diseases and growing demand for computational assistance are key factors surging global market growth  Market size: USD...
New Logo.png
Provectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
June 04, 2021 09:00 ET | Provectus Biopharmaceuticals Inc.
     — Systemic disease control achieved in heavily pre-treated liver cancer patients      — 83% DCR; median PFS of 9.2 months; median OS of 22.5 months; half of patients undergoing response...
22157.jpg
The Worldwide Interventional Oncology Industry is Projected to Reach $2.9 Billion by 2026 at a CAGR of 6.8% from 2020
June 01, 2021 07:43 ET | Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires), Procedure (Thermal, Non-Thermal Ablation, TACE, TARE,...
Logo (3).png
Electric Vehicle (EV) Market Worth $2,495.4 Billion by 2027, Growing at a CAGR of 33.6% From 2020- Exclusive Report by Meticulous Research®
May 11, 2021 07:10 ET | Meticulous Market Research Pvt. Ltd.
London, May 11, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Electric Vehicle (EV) Market by Vehicle Type (Passenger Vehicles, LCVs, HCVs, Two-wheelers, e-Scooters &...